UBS Group AG

Position in BRNS — Barinthus Biotherapeutics plc.

CIK 1610520 ZURICH, V8

Position in BRNS

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$665

-$1,541 QoQ

Shares Held

1,008

-68.0% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#15

of 15 holders

Holding Since

Dec 2021

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,675,801 across 560 Biotechnology names. BRNS ranks #520 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RVMD	Revolution Medicines, Inc.	5,450,825	$1,020,369,609
2	ROIV	Roivant Sciences Ltd.	17,466,641	$618,144,423
3	PTGX	Protagonist Therapeutics, Inc	3,399,221	$416,676,508
4	VRTX	Vertex Pharmaceuticals Inc / Ma	712,259	$353,800,411
5	MRNA	Moderna, Inc.	4,463,211	$312,558,664
6	INSM	INSMED Inc	2,584,446	$275,553,630
7	ABVX	Abivax S.A.	1,844,918	$245,853,771
8	MDGL	Madrigal Pharmaceuticals, Inc.	401,708	$215,697,109

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$665	1,008	-68.0%	Shares	Defined	2026-08-13
2025-12-31	$2,206	3,152	+24146.2%	Shares	Defined	2026-01-29
2025-09-30	$16	13	-99.1%	Shares	Defined	2025-11-13
2024-09-30	$1,704	1,432	-98.3%	Shares	Sole	2024-11-14
2024-06-30	$121,313	86,653	+5501.4%	Shares	Defined	2024-08-14
2024-03-31	$3,681	1,547	0.0%	Shares	Sole	2024-05-13
2023-12-31	$5,708	1,547	+1638.2%	Shares	Sole	2024-02-09
2023-09-30	$275	89	-91.0%	Shares	Sole	2023-11-09
2023-06-30	$2,045	993	-73.5%	Shares	Sole	2023-08-11
2022-12-31	$8,814	3,751	-27.7%	Shares	Sole	2023-02-08
2022-09-30	$16,601	5,188	+1022.9%	Shares	Sole	2022-11-10
2022-06-30	$2,055	462	-76.4%	Shares	Sole	2022-08-10
2022-03-31	$10,171	1,956	+241.4%	Shares	Sole	2022-05-16
2021-12-31	$6,366	573	—	Shares	Sole	2022-02-14
No filing history on record for this holder in this stock.